Cargando…
Heparan sulfate is a plasma biomarker of acute cellular allograft rejection
Despite advances in management of immunosuppression, graft rejection remains a significant clinical problem in solid organ transplantation. Non-invasive biomarkers of graft rejection can facilitate earlier diagnosis and treatment of acute rejection. The purpose of this study was to investigate the p...
Autores principales: | Barbas, Andrew S., Lin, Liwen, McRae, MacKenzie, MacDonald, Andrea L., Truong, Tracy, Yang, Yiping, Brennan, Todd V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080752/ https://www.ncbi.nlm.nih.gov/pubmed/30086133 http://dx.doi.org/10.1371/journal.pone.0200877 |
Ejemplares similares
-
T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice
por: Espinosa, Jaclyn R., et al.
Publicado: (2018) -
Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023) -
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection
Publicado: (1990) -
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018) -
Therapies for Chronic Allograft Rejection
por: Kim, Min Young, et al.
Publicado: (2021)